| FDA-approved trifluoromethyl group-containing drugs: a review of 20 years AS Nair, AK Singh, A Kumar, S Kumar, S Sukumaran, VP Koyiparambath, ... Processes 10 (10), 2054, 2022 | 54 | 2022 |
| Deciphering the detailed structure–activity relationship of coumarins as Monoamine oxidase enzyme inhibitors—an updated review VP Koyiparambath, K Prayaga Rajappan, TM Rangarajan, AG Al‐Sehemi, ... Chemical Biology & Drug Design 98 (4), 655-673, 2021 | 38 | 2021 |
| Trimethoxylated halogenated chalcones as dual inhibitors of MAO-B and BACE-1 for the treatment of neurodegenerative disorders VP Koyiparambath, JM Oh, A Khames, MA Abdelgawad, AS Nair, LR Nath, ... Pharmaceutics 13 (6), 850, 2021 | 27 | 2021 |
| Exploration of the detailed structure–activity relationships of isatin and their isomers as monoamine oxidase inhibitors S Kumar, AS Nair, MA Abdelgawad, B Mathew ACS omega 7 (19), 16244-16259, 2022 | 24 | 2022 |
| Revealing the role of the benzyloxy pharmacophore in the design of a new class of monoamine oxidase‐B inhibitors ST Sudevan, TM Rangarajan, AG Al‐Sehemi, AS Nair, VP Koyiparambath, ... Archiv der Pharmazie 355 (8), 2200084, 2022 | 14 | 2022 |
| Navigating into the chemical space of monoamine oxidase inhibitors by artificial intelligence and cheminformatics approach S Kumar, AS Nair, V Bhashkar, ST Sudevan, VP Koyiparambath, ... ACS omega 6 (36), 23399-23411, 2021 | 13 | 2021 |
| Development of halogenated pyrazolines as selective monoamine oxidase-B Inhibitors: Deciphering via molecular dynamics approach AS Nair, JM Oh, VP Koyiparambath, S Kumar, ST Sudevan, O Soremekun, ... Molecules 26 (11), 3264, 2021 | 13 | 2021 |
| Structural modifications on chalcone framework for developing new class of cholinesterase inhibitors G George, VP Koyiparambath, S Sukumaran, AS Nair, LK Pappachan, ... International Journal of Molecular Sciences 23 (6), 3121, 2022 | 12 | 2022 |
| Current and future nano-carrier-based approaches in the treatment of Alzheimer’s disease A Kumar, ST Sudevan, AS Nair, AK Singh, S Kumar, J Jose, T Behl, ... Brain Sciences 13 (2), 213, 2023 | 7 | 2023 |
| A review on benzimidazole scaffolds as inhibitors of Mycobacterium tuberculosis mycolyl-arabinogalactan-peptidoglycan complex biosynthesis V Bhaskar, S Kumar, AS Nair, KP Rajappan, ST Sudevan, DGT Parambi, ... Combinatorial Chemistry & High Throughput Screening 26 (4), 668-681, 2023 | 4 | 2023 |
| Unraveling the prevalence of various signalling pathways in non-small-cell lung cancer: A review AS Nair, AP Jayan, KR Anandu, VN Saiprabha, LK Pappachen Molecular and Cellular Biochemistry 478 (12), 2875-2890, 2023 | 3 | 2023 |
| Multifaceted roles of mitochondrial dysfunction in diseases: from powerhouses to saboteurs SS Prabhu, AS Nair, SV Nirmala Archives of Pharmacal Research 46 (9), 723-743, 2023 | 1 | 2023 |
| Effects of radiation exposure on brain health: a state of the art and new challenges J Jayan, H Roshi, FFP Ashraf, PG Nair, A Vijayakumar, AS Nair, ... Environmental Science and Pollution Research 29 (58), 87068-87081, 2022 | 1 | 2022 |
| In silico development of potential InhA inhibitors through 3D-QSAR analysis, virtual screening and molecular dynamics V Bhaskar, S Kumar, A Sujathan Nair, S Gokul, P Rajappan Krishnendu, ... Journal of Biomolecular Structure and Dynamics, 1-23, 2023 | | 2023 |
| Chitosan as potential carrier for drug delivery V Bhaskar, AS Nair, LK Pappachen Natural Biopolymers in Drug Delivery and Tissue Engineering, 127-156, 2023 | | 2023 |
Prof. Dr.Bijo Mathew (M.Pharm (Chem...Professor of Pharmaceutical Chemistry,Amrita School of Pharmacy,Amrita Vishwa VidyapeethamVerified email at aims.amrita.edu
